期刊文献+

携带质粒的PLGA纳米粒-超声微泡复合体的构建及细胞相容性研究

Construction of pIRES-tPA-DsRed Express2-encapsulated PLGA Nanoparticles-ultrasound Microbubble Complexes and Study on Their Cell Compatibility
下载PDF
导出
摘要 目的构建携带tPA基因质粒的聚乳酸-羟基乙酸共聚物(PLGA)纳米粒-超声微泡复合体,检测其理化性质、体外缓释方式、细胞相容性。方法应用双次乳化法制备携有tPA基因质粒的PLGA纳米粒;应用薄膜水化超声法制备阳离子超声微泡;两者通过静电吸附作用,形成质粒-纳米粒-超声微泡复合体(plasmid encapsulated nanoparticle-mi-crobubble complex,PENMC)。检测PLGA纳米粒的质粒载量,该复合体PENMC的质粒载量;检测PLGA纳米粒及复合体体外缓释质粒的情况;CCK-8法检测纳米粒及复合体PENMC的细胞毒性。结果检测携带质粒的纳米粒粒径为(217.2±2.2)nm,zeta电位为(-15.24±0.83)mV。微泡平均大小为(3.2±1.5)μm,zeta电位为(13.66±2.05)mV。微泡浓度为(4.3±1.1)×108/mL。PENMC平均直径为(4.6±1.7)μm,zeta电位为(2.23±1.45)mV。浓度为(3.0±1.3)×108/mL。1mg PLGA纳米粒载有质粒(42.3±2.1)μg。1mL PENMC中带有质粒(20.5±2.7)μg。PLGA纳米粒及复合体PENMC前7d累计释放量均为(57±3)%。起始段短时间内快速释放,后呈现稳定、缓慢释放。体外细胞毒实验证实PLGA纳米粒及复合体PENMC均未见明显细胞毒性效应。结论所构建的纳米粒-超声微泡复合体显示出较好的缓释效果,较低的细胞毒性,为后续将其应用于基因治疗奠定了实验基础。 Objective To construct pIRES-tPA-DsRed Express2-encapsulated PLGA nanoparticles-ultrasound microbubble complexes and investigate their physical and chemical properties,the in vitro plasmid release manner,and cell compatibility.Methods pIRES-tPA-DsRed Express2-encapsulated PLGA nanoparticles were prepared by double emulsion method.Cationic ultrasound microbubbles were prepared by thin-film hydration method.Plasmid-encapsuled nanoparticle-microbubble complexes(PENMC)were created by electrostatic adsorption.The plasmid loads in PLGA nanoparticles and PENMC were assayed,respectively.The in vitro plasmid release manner and the cytotoxicity of PLGA nanoparticles and PENMC were examined.Results The size and zeta potential of the plasmid-encapsulated PLGA nanoparticles were(217.2±2.2)nm and(-15.24±0.83)mV,respectively.The average size and zeta potential of the cationic microbubbles were(3.2±1.5)μm and(13.66±2.05)mV,while the concentration was(4.3±1.1)×108/mL.The average size of PENMC was(4.6±1.7)μm,the zeta potential(2.23±1.45)mV and the concentration(3.0±1.3)×108/mL.The plasmid loads were(20.5±2.7)μg/mL and(42.3±2.1)μg/mg in PENMC and PLGA nanoparticles,respectively.The cumulative plasmid release rate was(57±3)%in the first seven days in both PLGA nanoparticles and PENMC groups.The plasmids were initially released rapidly and a short time later,slow and stable release pattern was presented.There was little cytotoxicity in PLGA nanoparticles and PENMC.Conclusion The PENMC with a good release pattern and low cytotoxicity may be used for gene therapy in future.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2013年第4期377-381,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.30872543)
关键词 纳米粒 超声微泡造影剂 组织型纤溶酶原激活因子 抗凝治疗 非病毒载体 nanoparticle ultrasound microbubble contrast agent human tissue-type plasminogen activator factor anticoagulant therapy nonviral vector
  • 相关文献

参考文献14

  • 1Borden M A,Caskey C F,Little E,et al.DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles[J].Langmuir,2007,23(18):9401-9408.
  • 2Vinogradov S V,Bronich T K,Kabanov A V.Nanosized cationic hydrogels for drug delivery:preparation,properties and interactions with cells[J].Adv Drug Deliv Rev,2002,54(1):135-147.
  • 3Allen T M,Cullis P R.Drug delivery systems:entering the mainstream[J].Science,2004,303(5665):1818-1822.
  • 4Xiang S D,Selomulya C,Ho J,et al.Delivery of DNA vaccines:an overview on the use of biodegradable polymeric and magnetic nanoparticles[J].Wiley Interdiscip Rev Nanomed Nanobiotechnol,2010,2(3):205-218.
  • 5Kumari A,Yadav S K,Yadav S C.Biodegradable polymeric nanoparticles based drug delivery systems[J].Colloids Surf B Biointerfaces,2010,75(1):1-18.
  • 6Bejjani R A,BenEzra D,Cohen H,et al.Nanoparticles for gene delivery to retinal pigment epithelial cells[J].Mol Vis,2005,11(2):124-132.
  • 7Luby T M,Cole G,Baker L,et al.Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1[J].Clin Immunol,2004,112(1):45-53.
  • 8Adomako M,St-Hilaire S,Zheng Y,et al.Oral DNA vaccination of rainbow trout,Oncorhynchus mykiss (Walbaum),against infectious haematopoietic necrosis virus using PLGA[Poly(D,L-Lactic-Co-Glycolic Acid)]nanoparticles[J].J Fish Dis,2012,35(3):203-214.
  • 9Wesselinova D.Current major cancer targets for nanoparticle systems[J].Curr Cancer Drug Targets,2011,11(2):164-183.
  • 10Vandenbroucke R E,Lentacker I,Demeester J,et al.Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles[J].J Control Release,2008,126(3):265-273.

二级参考文献17

  • 1Capila I, Ltnhardt R J. Heparn-proten irtteractions[-.13. An- gew Chem Int Edit,2002,41(3):390-412.
  • 2Linhardt R J, Claude S. Hudson Award address in carbohy- drate chemistry. Heparin:structure and activity[J]. J Med Chem,2003,46(13)2551-2564.
  • 3Schnieders J,Gbureck U,Thull R, et al. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycol- ic acid) composite bone cement [J]. Biomaterials, 2006, 27 (23) : 4239-4249.
  • 4Makadia H K, Siegel S J. Poly lactic-co-glycolic acid(PLGA) as biodegradable controlled drug delivery carrier[J]. Poly- mers(Basel) ,2011,3(3) 1377-1397.
  • 5Smith P K, Mallia A K, Hermanson G T. Colorimetric method for the assay of heparin content in immobilized heparin prepa- rations[J]. Anal Biochem, 1980,109(2) 466-473.
  • 6Vanderhoff J W,E1-Aasser M S, Ugelstad J. Polymer emulsi- fication process[P]. U S Pat, 1979,4(177) : 177.
  • 7Quintanar-Guerrero D,Allemann E, Fessi H, et al. Pseudola- tex preparation using a novel emulsion-diffusion process in- volving direct displacement ofpartially water-miscible sol- vents by distillation[J]. Int J Pharm, 1999,188(2) : 155-164.
  • 8Zambaux M F,Bonneaux F,Gref R, et al. Influence of experi- mental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method[J]. J Control Release, 1998,50(1/3) : 31-40.
  • 9Cohen-Sela E, Chorny M, Koroukhov N, et al. A new double emulsion solvent diffusion technique for encapsulating hydro- philic molecules in PLGA nanoparticles[J]. J Control Re lease 2009,133(2) : 90-95.
  • 10Yang Z, Birkenhauer P, Julmy F, et al. Sustained release of heparin from polymeric particles for inhibition of human vas cular smooth muscle cell proliferation[J]. J Control Release, 1999,60(2/3) :269-277.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部